Stay updated with breaking news from Research Square. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent article posted to the Research Square* preprint server demonstrated that high body temperature elevates gut microbiota-reliant host resistance against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A viral infection.
Researchers discuss the development of an electronic nose device for the detection of SARS-CoV-2.
Researchers investigated the residual SARS-CoV-2 antigen found in long COVID-19 patients.
JERUSALEM — Pfizer Inc's antiviral treatment Paxlovid reduces COVID-19 hospitalization and death rates in vaccinated and unvaccinated patients 65 years
A recent phase 1/2 study under review at the Nature Portfolio journal and posted to the Research Square* preprint server demonstrated that a peptide-centered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell activator, CoVac-1, was efficient in B-cell deficient people.